Han Siong Toh

1.5k total citations
55 papers, 1.1k citations indexed

About

Han Siong Toh is a scholar working on Infectious Diseases, Molecular Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Han Siong Toh has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 15 papers in Molecular Medicine and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Han Siong Toh's work include Antibiotic Resistance in Bacteria (15 papers), COVID-19 Clinical Research Studies (6 papers) and Heart Failure Treatment and Management (6 papers). Han Siong Toh is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), COVID-19 Clinical Research Studies (6 papers) and Heart Failure Treatment and Management (6 papers). Han Siong Toh collaborates with scholars based in Taiwan, Belgium and United States. Han Siong Toh's co-authors include Yin-Ching Chuang, Hung-Jen Tang, Chia‐Te Liao, Wei‐Ting Chang, Wen‐Liang Yu, Wen‐Chien Ko, Hung-Jen Tang, Tzu-Chieh Weng, Yao-Shen Chen and Chi-Chung Chen and has published in prestigious journals such as Kidney International, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

Han Siong Toh

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han Siong Toh Taiwan	18	286	261	251	224	149	55	1.1k
José Antonio Lepe Spain	20	285 1.0×	389 1.5×	522 2.1×	213 1.0×	151 1.0×	133	1.4k
Bahareh Hajikhani Iran	21	234 0.8×	556 2.1×	211 0.8×	360 1.6×	82 0.6×	74	1.2k
Wei Yu China	21	451 1.6×	112 0.4×	220 0.9×	237 1.1×	57 0.4×	90	1.2k
Marco Cassone United States	23	202 0.7×	494 1.9×	571 2.3×	583 2.6×	143 1.0×	72	1.9k
Ronit Zaidenstein Israel	20	266 0.9×	91 0.3×	209 0.8×	107 0.5×	49 0.3×	69	1.2k
Min‐Chi Lu Taiwan	28	756 2.6×	446 1.7×	343 1.4×	525 2.3×	88 0.6×	81	1.8k
Guillermo Ruíz-Carrascoso Spain	17	457 1.6×	255 1.0×	235 0.9×	127 0.6×	42 0.3×	77	951
Diamantis P. Kofteridis Greece	16	288 1.0×	297 1.1×	262 1.0×	121 0.5×	66 0.4×	60	1.0k
Maria Panopoulou Greece	16	156 0.5×	144 0.6×	267 1.1×	119 0.5×	116 0.8×	70	954
Uma Chaudhary India	19	424 1.5×	203 0.8×	350 1.4×	370 1.7×	158 1.1×	101	1.4k

Countries citing papers authored by Han Siong Toh

Since Specialization

Citations

This map shows the geographic impact of Han Siong Toh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Siong Toh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Siong Toh more than expected).

Fields of papers citing papers by Han Siong Toh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Siong Toh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Siong Toh. The network helps show where Han Siong Toh may publish in the future.

Co-authorship network of co-authors of Han Siong Toh

This figure shows the co-authorship network connecting the top 25 collaborators of Han Siong Toh. A scholar is included among the top collaborators of Han Siong Toh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Siong Toh. Han Siong Toh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Yu‐Min, et al.. (2025). Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists and sodium–glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease phenotypes: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 11(2). 174–189. 2 indexed citations

Hua, Yi‐Ming, et al.. (2025). A systematic review and meta-analysis of randomized controlled trials of systemic antibiotics for diabetes-related foot infections. Diabetes and Vascular Disease Research. 22(1). 1507153981–1507153981.

Toh, Han Siong, et al.. (2024). Assessing the Diversity and Determinants of Health-Related Quality of Life Measures in Patients with Acute Heart Failure. ESC Heart Failure. 11(4). 1963–1970. 1 indexed citations

Huang, Po‐Yu, Jheng‐Yan Wu, Tinghui Liu, et al.. (2023). The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine. 10. 1171294–1171294. 6 indexed citations

Liao, Chia‐Te, Wei‐Ting Chang, Yi‐Ming Hua, et al.. (2021). Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region. Frontiers in Cardiovascular Medicine. 8. 750381–750381. 29 indexed citations

Chen, Po-Jung, et al.. (2021). Topical antibiotic prophylaxis for surgical wound infections in clean and clean-contaminated surgery: a systematic review and meta-analysis. BJS Open. 5(6). 17 indexed citations

Chan, Khee‐Siang, Fu‐Wen Liang, Hung-Jen Tang, Han Siong Toh, & Wen‐Liang Yu. (2020). Collateral benefits on other respiratory infections during fighting COVID-19. Medicina Clínica (English Edition). 155(6). 249–253. 5 indexed citations

Chan, Khee-Siang, Fu‐Wen Liang, Hung-Jen Tang, Han Siong Toh, & Wen‐Liang Yu. (2020). Collateral benefits on other respiratory infections during fighting COVID-19. Medicina Clínica. 155(6). 249–253. 17 indexed citations

Chen, Chi‐Chung, Chih‐Cheng Lai, Hui-Ling Huang, et al.. (2020). Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae. Journal of Microbiology Immunology and Infection. 54(3). 447–456. 37 indexed citations

10.

Liao, Chia‐Te, Han Siong Toh, Wei‐Ting Chang, et al.. (2020). Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases. Cardiovascular Drugs and Therapy. 35(3). 539–547. 6 indexed citations

11.

Liao, Chia‐Te, Chun-Ting Yang, Han Siong Toh, et al.. (2020). Association of adherence to antiretroviral therapy with economic burden of cardiovascular disease in HIV-infected population. European Journal of Preventive Cardiology. 28(3). 326–334. 5 indexed citations

12.

Toh, Han Siong, Shihchen Kuo, Hung-Jen Tang, et al.. (2019). Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy. International Journal of Infectious Diseases. 91. 44–49. 5 indexed citations

13.

Lai, Chih‐Cheng, Chi‐Chung Chen, Ying-Chen Lu, et al.. (2018). Simultaneous three Enterobacteriaceae with different <em>bla</em> <sub>NDM-1</sub>-encoding plasmids in a patient transferred from mainland China to Taiwan. Infection and Drug Resistance. Volume 11. 2555–2560. 7 indexed citations

14.

Toh, Han Siong, Chia‐Te Liao, Chung‐Han Ho, & Chia-Chun Wu. (2014). Association between stroke and HIV infection: A population-based study in Taiwan. International Journal of Infectious Diseases. 21. 123–123. 1 indexed citations

15.

Lu, Po‐Liang, Yung-Ching Liu, Han Siong Toh, et al.. (2012). Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). International Journal of Antimicrobial Agents. 40. S37–S43. 165 indexed citations

16.

Liu, Yuag-Meng, Yao-Shen Chen, Han Siong Toh, et al.. (2012). In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). International Journal of Antimicrobial Agents. 40. S11–S17. 32 indexed citations

17.

Toh, Han Siong, Yin-Ching Chuang, Chi-Chang Huang, et al.. (2012). Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006–2010. International Journal of Antimicrobial Agents. 40. S18–S23. 8 indexed citations

18.

Toh, Han Siong, et al.. (2011). Risk factors associated with Sphingomonas paucimobilis infection. Journal of Microbiology Immunology and Infection. 44(4). 289–295. 58 indexed citations

19.

Peng, Chien‐Fang, et al.. (2010). Use of Inverse PCR for Analysis of Class 1 Integrons Carrying an Unusual 3′ Conserved Segment Structure. Antimicrobial Agents and Chemotherapy. 55(2). 943–945. 15 indexed citations

20.

Toh, Han Siong, et al.. (2008). The Case ∣ Generalized petechiae and acute renal failure. Kidney International. 73(12). 1443–1444. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact